JP2009545756A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545756A5
JP2009545756A5 JP2009523338A JP2009523338A JP2009545756A5 JP 2009545756 A5 JP2009545756 A5 JP 2009545756A5 JP 2009523338 A JP2009523338 A JP 2009523338A JP 2009523338 A JP2009523338 A JP 2009523338A JP 2009545756 A5 JP2009545756 A5 JP 2009545756A5
Authority
JP
Japan
Prior art keywords
protein
peptide sequence
peptide
identifying
aggregation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009523338A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009545756A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2007/002789 external-priority patent/WO2008015384A1/en
Publication of JP2009545756A publication Critical patent/JP2009545756A/ja
Publication of JP2009545756A5 publication Critical patent/JP2009545756A5/ja
Pending legal-status Critical Current

Links

JP2009523338A 2006-08-04 2007-07-24 タンパク質凝集を予測し凝集阻害物質を設計する方法 Pending JP2009545756A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82155306P 2006-08-04 2006-08-04
PCT/GB2007/002789 WO2008015384A1 (en) 2006-08-04 2007-07-24 Method for predicting protein aggregation and designing aggregation inhibitors

Publications (2)

Publication Number Publication Date
JP2009545756A JP2009545756A (ja) 2009-12-24
JP2009545756A5 true JP2009545756A5 (cg-RX-API-DMAC7.html) 2010-09-09

Family

ID=38573441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523338A Pending JP2009545756A (ja) 2006-08-04 2007-07-24 タンパク質凝集を予測し凝集阻害物質を設計する方法

Country Status (11)

Country Link
US (1) US8290713B2 (cg-RX-API-DMAC7.html)
EP (1) EP2047393A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009545756A (cg-RX-API-DMAC7.html)
KR (1) KR20090047470A (cg-RX-API-DMAC7.html)
CN (1) CN101501694B (cg-RX-API-DMAC7.html)
AU (1) AU2007280282B2 (cg-RX-API-DMAC7.html)
CA (1) CA2657847A1 (cg-RX-API-DMAC7.html)
EA (1) EA016884B1 (cg-RX-API-DMAC7.html)
IL (1) IL196551A (cg-RX-API-DMAC7.html)
SG (1) SG173405A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008015384A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
RU2442793C2 (ru) 2005-11-30 2012-02-20 Эбботт Лэборетриз АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
PL1976877T5 (pl) 2005-11-30 2017-09-29 Abbvie Inc Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
GB2455102A (en) * 2007-11-28 2009-06-03 Cambridge Entpr Ltd Protein Aggregation Prediction Systems
WO2009128948A1 (en) 2008-04-17 2009-10-22 Peptimmune, Inc. Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
CN110187119B (zh) * 2008-10-31 2022-07-29 耶鲁大学 子痫前期检测和治疗的方法和组合物
JP2013508308A (ja) * 2009-10-23 2013-03-07 ガーバン インスティテュート オブ メディカル リサーチ 修飾可変ドメイン分子、ならびにその産生および使用方法
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
FI20105629A0 (fi) * 2010-06-03 2010-06-03 Estaja Oy Menetelmä lipidiaktivoituvien entsyymien peptidi-inhibiittoreiden valmistamiseksi ja menetelmällä valmistettuja peptidejä
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US20120108904A1 (en) * 2010-10-20 2012-05-03 Yong Ma Cleaner for endoscope
CN103772487B (zh) * 2012-10-24 2015-11-25 国家纳米科学中心 一种抑制人胰淀素聚集或毒性的多肽、试剂及其应用
US9618524B2 (en) * 2014-03-26 2017-04-11 Plaxgen Inc. Method, composition, isolation and identification of a plaque particle and related biomarker
CN104502219B (zh) * 2014-12-18 2017-09-29 江苏大学 一种淀粉样多肽聚集抑制剂及其抑制效果评估和验证方法
SG11201705275VA (en) * 2015-01-06 2017-07-28 Univ North Carolina State Modeling ribosome dynamics to optimize heterologous protein production
GB201600176D0 (en) * 2016-01-06 2016-02-17 Cambridge Entpr Ltd Method of identifying novel protein aggregation inhibitors based on chemical kinetics
WO2017127679A1 (en) * 2016-01-21 2017-07-27 Protein Dynamic Solutions Llc Method and system for spectral data analysis
MX2019000047A (es) * 2016-06-29 2019-07-04 Univ California Inhibidores peptídicos de la acumulación de alfa-sinucleína basados en estructuras.
CN106501550A (zh) * 2016-12-09 2017-03-15 江苏大学 基于原子力显微镜氨基酸影响鱼蛋白聚集行为的评价方法
CN111653310B (zh) * 2020-06-29 2023-06-20 北京大学深圳研究生院 含二硫键多肽的结构预测方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020079731A (ko) * 1999-11-05 2002-10-19 액소닉스, 인코포레이티드. 아밀로이드, 아밀로이드-유사 침착물, 또는 β-쉬이트가풍부한 그의 병리학적 전구체로의 비정상적 단백질 폴딩과관련된 질환의 치료에 있어서 생체내에서 사용하기에적합한 펩티드 동족체 및 유사체
MXPA05013692A (es) * 2003-06-23 2006-03-13 Neurochem Int Ltd Metodos para tratar trastornos por acumulacion de proteina.
GB0325817D0 (en) * 2003-11-05 2003-12-10 Univ Cambridge Tech Method and apparatus for assessing polypeptide aggregation

Similar Documents

Publication Publication Date Title
Liu et al. Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
JP2020511672A5 (cg-RX-API-DMAC7.html)
JP2014518883A5 (cg-RX-API-DMAC7.html)
JP2018534932A5 (cg-RX-API-DMAC7.html)
Mukherjee et al. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer’s disease
CN103328501B (zh) 新的生物标记及其在诊断、治疗孤独症中的用途
de Graaf et al. A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies
TW201014602A (en) Prostaglandin E2 binding proteins and uses thereof
RU2010151725A (ru) Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их
EP2352021A1 (en) Peptide for use in simultaneous protein quantification of metabolizing enzymes using mass spectrometric analysis apparatus
JP2011523550A5 (cg-RX-API-DMAC7.html)
WO2008087035A3 (en) Screening method for anti-diabetic compounds
RU2011103199A (ru) Антитела против cdh3, меченные радиоизотопной меткой, и их применение
JP2013539454A5 (cg-RX-API-DMAC7.html)
JP2010527939A5 (cg-RX-API-DMAC7.html)
JP2025063133A (ja) 原発性免疫不全症、シスチン症、及びウィルソン病に関する新生児スクリーニング
Wang et al. All-atom simulations reveal how single-point mutations promote serpin misfolding
Cui et al. Cathepsin D: Removal strategy on protein A chromatography, near real time monitoring and characterisation during monoclonal antibody production
WO2022254430A1 (en) Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease
WO2024020579A1 (en) Antibodies binding to human pad4 and uses thereof
EP4255486A1 (en) Trem2 agonist biomarkers and methods of use thereof
WO2019230856A1 (ja) Nav1.7モノクローナル抗体
JP2025182711A (ja) 遺伝子発現アッセイを使った予測ペプチド受容体放射性核種療法
Guo et al. Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: a propensity score-adjusted and-matched comparison analysis
Han et al. Electron transfer dissociation of iTRAQ labeled peptide ions